General Information of the Compound
| Compound ID |
CP0444051
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[[(3R)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]-2-[(6-methoxy-1H-indol-7-yl)oxy]ethanamine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C20H22N2O4
|
||||||||||||||||||
| Molecular Weight |
354.406
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc2cc[nH]c2c1OCCNC[C@@H]1COc2ccccc2O1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C20H22N2O4/c1-23-18-7-6-14-8-9-22-19(14)20(18)24-11-10-21-12-15-13-25-16-4-2-3-5-17(16)26-15/h2-9,15,21-22H,10-13H2,1H3/t15-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
UOWWWPYFAPQMPE-OAHLLOKOSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01089, Alpha-1A adrenergic receptor
Protein ID: PT01007, Alpha-1B adrenergic receptor
Protein ID: PT01004, Alpha-1D adrenergic receptor